X-30852863-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152787.5(TAB3):c.1625G>A(p.Arg542Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000579 in 1,209,557 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152787.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAB3 | NM_152787.5 | c.1625G>A | p.Arg542Gln | missense_variant | 7/11 | ENST00000288422.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAB3 | ENST00000288422.4 | c.1625G>A | p.Arg542Gln | missense_variant | 7/11 | 5 | NM_152787.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000894 AC: 1AN: 111841Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34023
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183026Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67536
GnomAD4 exome AF: 0.00000547 AC: 6AN: 1097716Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 3AN XY: 363074
GnomAD4 genome AF: 0.00000894 AC: 1AN: 111841Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34023
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.1625G>A (p.R542Q) alteration is located in exon 7 (coding exon 3) of the TAB3 gene. This alteration results from a G to A substitution at nucleotide position 1625, causing the arginine (R) at amino acid position 542 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at